Erasca (ERAS) Short Interest Ratio & Short Volume $1.46 +0.04 (+2.46%) As of 10:05 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Erasca Short Interest DataErasca (ERAS) has a short interest of 20.96 million shares, representing 13.05% of the float (the number of shares available for trading by the public). This marks a -2.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 13.0, indicating that it would take 13.0 days of the average trading volume of 1.67 million shares to cover all short positions.Current Short Interest20,960,000 sharesPrevious Short Interest21,500,000 sharesChange Vs. Previous Month-2.51%Dollar Volume Sold Short$31.02 millionShort Interest Ratio13.0 Days to CoverLast Record DateJune 15, 2025Outstanding Shares283,287,000 sharesFloat Size160,600,000 sharesShort Percent of Float13.05%Today's Trading Volume19,330 sharesAverage Trading Volume1,666,552 sharesToday's Volume Vs. Average1% Short Selling Erasca? Sign up to receive the latest short interest report for Erasca and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartERAS Short Interest Over TimeERAS Days to Cover Over TimeERAS Percentage of Float Shorted Over Time Erasca Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202520,960,000 shares $31.02 million -2.5%13.1%13 $1.48 5/31/202521,500,000 shares $30.42 million +2.4%13.4%12.4 $1.42 5/15/202520,990,000 shares $26.66 million -3.9%13.1%13 $1.27 4/30/202521,830,000 shares $31.87 million -7.2%13.3%13.4 $1.46 4/15/202523,520,000 shares $27.99 million -13.6%14.4%14.6 $1.19 3/31/202527,220,000 shares $37.29 million -17.8%16.6%16.7 $1.37 3/15/202533,100,000 shares $47.66 million -2.2%20.2%22.5 $1.44 2/28/202533,860,000 shares $46.39 million -1.9%20.7%25.5 $1.37 2/15/202534,520,000 shares $54.20 million +2.3%21.1%26.2 $1.57 1/31/202533,760,000 shares $63.81 million +1.8%20.7%23.4 $1.89 Get the Latest News and Ratings for ERAS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Erasca and its competitors with MarketBeat's FREE daily newsletter. 1/15/202533,150,000 shares $63.65 million +1.1%20.3%22.9 $1.92 12/31/202432,790,000 shares $82.30 million +3.9%20.1%23.4 $2.51 12/15/202431,560,000 shares $80.79 million -2.1%19.3%21.3 $2.56 11/30/202432,230,000 shares $92.18 million +0.3%19.7%18.1 $2.86 11/15/202432,150,000 shares $85.84 million -2.5%19.7%17 $2.67 10/31/202432,970,000 shares $85.39 million -2.2%18.8%16.3 $2.59 10/15/202433,700,000 shares $94.70 million 0.0%19.2%17.8 $2.81 9/30/202433,710,000 shares $92.03 million +24.7%19.2%15.7 $2.73 9/15/202427,030,000 shares $80.28 million +9.0%15.4%11 $2.97 8/31/202424,810,000 shares $71.70 million +5.9%14.9%12 $2.89 8/15/202423,420,000 shares $63.47 million +5.2%14.1%10.2 $2.71 7/31/202422,260,000 shares $70.12 million +2.1%13.4%9 $3.15 7/15/202421,810,000 shares $67.17 million +9.0%13.1%9.5 $3.08 6/30/202420,010,000 shares $47.22 million +30.7%12.0%9.9 $2.36 6/15/202415,310,000 shares $33.22 million +8.7%9.2%9.5 $2.17 5/31/202414,080,000 shares $35.48 million +31.2%7.9%9.5 $2.52 5/15/202410,730,000 shares $20.28 million +2.1%6.6%7.6 $1.89 4/30/202410,510,000 shares $21.13 million +10.9%10.2%13.5 $2.01 4/15/20249,480,000 shares $18.96 million +6.9%10.6%12.1 $2.00 3/31/20248,870,000 shares $18.27 million -1.7%9.9%11 $2.06 3/15/20249,020,000 shares $19.30 million -8.9%10.1%11.2 $2.14 2/29/20249,900,000 shares $23.56 million -3.6%11.1%8.4 $2.38 2/15/202410,270,000 shares $18.38 million +0.5%11.5%8.3 $1.79 1/31/202410,220,000 shares $17.07 million -1.0%11.0%9.3 $1.67 1/15/202410,320,000 shares $19.92 million +7.2%11.2%9.3 $1.93 12/31/20239,630,000 shares $20.51 million -12.4%10.4%8.4 $2.13 12/15/202310,990,000 shares $20.55 million +21.4%11.9%9.6 $1.87 11/30/20239,050,000 shares $15.39 million +3.8%9.8%8.8 $1.70 11/15/20238,720,000 shares $20.23 million +10.8%9.3%14.5 $2.32 10/31/20237,870,000 shares $18.18 million +7.1%8.4%12.4 $2.31A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 10/15/20237,350,000 shares $17.20 million -0.3%7.9%11.7 $2.34 9/30/20237,370,000 shares $14.52 million -12.6%8.0%13.3 $1.97 9/15/20238,430,000 shares $21.75 million -5.5%9.1%16.6 $2.58 8/31/20238,920,000 shares $23.10 million +1.1%9.7%15.8 $2.59 8/15/20238,820,000 shares $22.45 million -17.0%8.4%14 $2.55 7/31/202310,630,000 shares $28.06 million -1.5%11.6%17.1 $2.64 7/15/202310,790,000 shares $28.38 million -0.6%12.7%16.6 $2.63 6/30/202310,850,000 shares $29.95 million +11.2%13.1%15.3 $2.76 6/15/20239,760,000 shares $27.04 million -4.5%11.8%11.7 $2.77 5/31/202310,220,000 shares $27.70 million -1.2%12.4%11.5 $2.71 5/15/202310,340,000 shares $30.61 million -9.2%12.5%11.2 $2.96 4/30/202311,390,000 shares $31.44 million -0.9%13.8%11.8 $2.76 4/15/202311,490,000 shares $33.55 million +1.0%13.9%11 $2.92 3/31/202311,380,000 shares $34.25 million +12.0%13.8%10.3 $3.01 3/15/202310,160,000 shares $32.41 million +18.7%12.3%8.9 $3.19 2/28/20238,560,000 shares $30.82 million +9.2%11.3%7.2 $3.60 2/15/20237,840,000 shares $30.03 million -0.1%10.3%7 $3.83 1/31/20237,850,000 shares $31.40 million -2.6%11.3%7 $4.00 1/15/20238,060,000 shares $33.53 million -22.9%11.6%7.5 $4.16 12/30/202210,460,000 shares $45.08 million -0.5%13.9%10.8 $4.31 12/15/202210,510,000 shares $50.13 million -27.3%17.3%11.8 $4.77 11/30/202214,460,000 shares $109.17 million -9.5%21.8%22 $7.55 11/15/202215,970,000 shares $130.47 million -4.0%24.1%22.6 $8.17 10/31/202216,640,000 shares $135.95 million -5.0%25.8%26.1 $8.17 10/15/202217,520,000 shares $125.27 million -4.2%27.1%28.8 $7.15 9/30/202218,290,000 shares $142.66 million +10.9%28.3%34.4 $7.80 9/15/202216,490,000 shares $144.29 million +4.7%25.6%32.1 $8.75 8/31/202215,750,000 shares $142.07 million +4.3%24.5%38.7 $9.02 8/15/202215,100,000 shares $161.27 million -1.4%23.5%42 $10.68 7/31/202215,310,000 shares $115.44 million -3.5%23.8%38.9 $7.54 7/15/202215,860,000 shares $105.47 million -1.3%24.7%37.9 $6.65 6/30/202216,070,000 shares $89.51 million +4.1%25.0%35 $5.57 6/15/202215,440,000 shares $74.42 million +5.2%24.0%30.8 $4.82 5/31/202214,680,000 shares $79.57 million +3.8%22.8%21.8 $5.42 5/15/202214,140,000 shares $82.01 million +5.2%22.0%20.7 $5.80 4/30/202213,440,000 shares $97.84 million +1.2%20.9%19.6 $7.28 4/15/202213,280,000 shares $114.61 million +7.7%20.7%17.4 $8.63 3/31/202212,330,000 shares $106.04 million +6.0%19.3%15.1 $8.60 3/15/202211,630,000 shares $124.09 million +7.0%18.2%14.1 $10.67 2/28/202210,870,000 shares $134.79 million +4.3%17.0%16.7 $12.40 2/15/202210,420,000 shares $129.62 million +9.8%16.1%16.7 $12.44 1/31/20229,490,000 shares $112.46 million +18.3%14.3%16.7 $11.85 1/15/20228,020,000 shares $103.78 million +8.8%12.0%16.3 $12.94 12/31/20217,370,000 shares $114.82 million +14.4%11.0%19.8 $15.58 12/15/20216,440,000 shares $87.91 million +16.5%9.6%20 $13.65 11/30/20215,530,000 shares $78.36 million +1.3%8.3%16.3 $14.17 11/15/20215,460,000 shares $103.52 million +20.0%8.2%16.4 $18.96 10/29/20214,550,000 shares $90.00 million +23.6%6.6%12.1 $19.78 10/15/20213,680,000 shares $65.50 million +18.3%5.3%9.6 $17.80 9/30/20213,110,000 shares $65.99 million +31.2%4.5%6.3 $21.22A new rule goes live in July — and the banks are quietly cashing in (Ad)A little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Street and the Big Banks… It gives them the green light to treat a certain tangible asset as equivalent to cold, hard cash. Not stocks. Not real estate. And definitely not the U.S. dollar. We're talking about something they don't want you to notice — because the fewer people who act on this, the better it is for them.To help you get started, we're giving away a FREE Wealth Protection Guide that shows you exactly how 9/15/20212,370,000 shares $49.86 million +15.6%3.4%4.5 $21.04 8/31/20212,050,000 shares $49.02 million +72.3%3.1%4.1 $23.91 8/13/20211,190,000 shares $23.90 million No Change1.9%2.1 $20.08 ERAS Short Interest - Frequently Asked Questions What is Erasca's current short interest? Short interest is the volume of Erasca shares that have been sold short but have not yet been covered or closed out. As of June 15th, investors have sold 20,960,000 shares of ERAS short. 13.05% of Erasca's shares are currently sold short. Learn More on Erasca's current short interest. What is a good short interest ratio for Erasca? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. ERAS shares currently have a short interest ratio of 13.0. Learn More on Erasca's short interest ratio. Which institutional investors are shorting Erasca? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Erasca: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Erasca? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 13.05% of Erasca's floating shares are currently sold short. Is Erasca's short interest increasing or decreasing? Erasca saw a drop in short interest in June. As of June 15th, there was short interest totaling 20,960,000 shares, a drop of 2.5% from the previous total of 21,500,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Erasca's float size? Erasca currently has issued a total of 283,287,000 shares. Some of Erasca's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Erasca currently has a public float of 160,600,000 shares. How does Erasca's short interest compare to its competitors? 13.05% of Erasca's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Erasca: ARS Pharmaceuticals, Inc. (30.27%), Schrodinger, Inc. (15.63%), Ocular Therapeutix, Inc. (9.27%), Vera Therapeutics, Inc. (20.84%), Biohaven Ltd. (12.68%), Evotec AG (0.23%), 89BIO (9.84%), Janux Therapeutics, Inc. (21.42%), ANI Pharmaceuticals, Inc. (10.44%), Edgewise Therapeutics, Inc. (16.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Erasca stock? Short selling ERAS is an investing strategy that aims to generate trading profit from Erasca as its price is falling. ERAS shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Erasca? A short squeeze for Erasca occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ERAS, which in turn drives the price of the stock up even further. How often is Erasca's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ERAS, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies SPRY Short Squeeze SDGR Short Squeeze OCUL Short Squeeze VERA Short Squeeze BHVN Short Squeeze EVO Short Squeeze ETNB Short Squeeze JANX Short Squeeze ANIP Short Squeeze EWTX Short Squeeze Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ERAS) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Erasca, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Erasca With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ERAS Stock Alerts